National Genomic Test Directory

Document first published:
Page updated:
Topic:
, ,
Publication type:

The 2019/2020 National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test. The 2019/2020 National Genomic Test Directory for rare and inherited disorders and cancer can be accessed below.

Summary

Rare and inherited disease – the 2019/2020 National Genomic Test Directory for rare and inherited disorders specifies the genomic tests commissioned by the NHS in England for rare and inherited disorders, the technology by which they are available, and the patients who will be eligible to access to a test.

Summary

This eligibility criteria document supplements the National Genomic Test Directory by setting out which patients should be considered for testing under that indication, and the requesting specialties is a list of the clinical specialties who would be expected to request the test. The Genomic Laboratory Hubs are currently transitioning to full implementation of the National Genomic Test Directory and eligibility criteria, as a result some tests may not yet be available. If you have any questions about the genomic testing available in your area, please contact your local Genomic Laboratory Hub.

Document

Summary

Cancer – the 2019/2020 National Genomic Test Directory for cancer specifies the genomic tests commissioned by the NHS in England for cancer, the technology by which they are available, and the patients who will be eligible to access to a test.

Summary

Frequently asked questions about the development process and operation of the National Genomic Test Directory, and its context within the NHS Genomic Medicine Service.